Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (91-100 of 548) with videos related to

Pageof 55
Sort By:
Cancer Treatment Reviews|October 25, 2020
Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatmentIsabelle Ray-Coquard, Mansoor Raza Mirza, Sandro Pignata, et al.
Bulletin Du Cancer|February 4, 2006
[News of the year 2005 in sarcomas]Jérôme Fayette, Pierre Méeus, Marie-Pierre Sunyach, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2023
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?Haider Mahdi, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Cancers|February 25, 2022
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and BeyondAxel de Bernardi, Armelle Dufresne, Florence Mishellany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trialsAndreas du Bois, Alexander Reuss, Philipp Harter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patientsPerrine Marec-Berard, Jean Yves Blay, Matthias Schell, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Mechanisms of resistance to endocrine therapies for breast cancerPierre Heudel, Paul Vilquin, Olivier Tredan, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
The Oncologist|October 3, 2019
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10Yvette Drew, Rebecca S Kristeleit, Ana Oaknin, et al.
Translational Gastroenterology and Hepatology|May 31, 2019
Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectivesMarie Laurent, Mehdi Brahmi, Armelle Dufresne, et al.
Pageof 55

Showing results (91-100 of 548) with videos related to

Sort By:
Pageof 55
Cancer Treatment Reviews|October 25, 2020
Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatmentIsabelle Ray-Coquard, Mansoor Raza Mirza, Sandro Pignata, et al.
Bulletin Du Cancer|February 4, 2006
[News of the year 2005 in sarcomas]Jérôme Fayette, Pierre Méeus, Marie-Pierre Sunyach, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2023
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?Haider Mahdi, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Cancers|February 25, 2022
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and BeyondAxel de Bernardi, Armelle Dufresne, Florence Mishellany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trialsAndreas du Bois, Alexander Reuss, Philipp Harter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patientsPerrine Marec-Berard, Jean Yves Blay, Matthias Schell, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Mechanisms of resistance to endocrine therapies for breast cancerPierre Heudel, Paul Vilquin, Olivier Tredan, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
The Oncologist|October 3, 2019
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10Yvette Drew, Rebecca S Kristeleit, Ana Oaknin, et al.
Translational Gastroenterology and Hepatology|May 31, 2019
Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectivesMarie Laurent, Mehdi Brahmi, Armelle Dufresne, et al.
Pageof 55